Genzyme, Buy-Out Target, Makes Mass Layoffs: National Employee Morale Day
Genzyme (NASDAQ: GENZ), the target of a buyout offer from Sanofi-Aventis, began to lay-off almost 10% of its workforce today. The company would not say exactly what the size of the cuts would be. Genzyme may have decided on the…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Genzyme may have decided on the move to increase margins. Sanofi-Aventis has offered $18.5 billion to buy the smaller company. Genzyme’s board has dismissed the offer as too low.
Sanofi-Aventis recently disclosed that it has lined-up $10 billion in financial backing to close a transaction.
Lay-offs to increase the value of the company? Cruel.
Douglas A. McIntyre
Contact [email protected] for any questions or corrections.